The Novel, Irreversible Proteasome Inhibitor PR-171 Demonstrates Potent Anti-Tumor Activity in Pre-Clinical Models of Multiple Myeloma, and Overcomes Bortezomib Resistance.

Autor: Kuhn, Deborah J., Chen, Qing *, Voorhees, Peter M., Strader, John S. *, Shenk, Kevin D. *, Sun, Congcong M. *, Demo, Susan D. *, Bennett, Mark K. *, van Leeuwen, Fred W. *, Orlowski, Robert Z.
Zdroj: In Blood 16 November 2006 108(11):3461-3461
Databáze: ScienceDirect